OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Clinical Epidemiology is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Visualizing the value of diagnostic tests and prediction models, part III. Numerical example with discrete risk groups and miscalibration	347
Meta-analysis of individual participant data and informed consent: a small step, but important and neglected	274
Guideline organizations’ guidance documents paper 10: developing recommendations about diagnostic tests and strategies	236
Empirical evaluation of the methods used in systematic reviews including observational studies and randomized trials	215
Strong and high-quality evidence synthesis needs Cochrane: a statement of support by the GRADE Guidance Group	167
Editorial Board	148
A general explanation of the counterfactual definition of confounding	147
Corrigendum to ‘Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches’ [Journal of Clinical Epidemiolog	146
Screening colonoscopy similarly prevented distal and proximal colorectal cancer: a prospective study among 55–69-year-olds	144
A Bayesian-adaptive decision-theoretic approach can reduce the sample sizes for multiarm exercise oncology trials	141
RETRACTED: Part II: a step-by-step guide to latent class analysis	133
Types and associated methodologies of overviews of reviews in health care: a methodological study with published examples	128
Two-decade health-related quality of life and performance on physical function tests in midaged women: findings from a prospective cohort study	127
Recording harms in randomized controlled trials of behavior change interventions: a scoping review and map of the evidence	123
Potential interactions between digoxin and direct oral anticoagulants: application of cohort & novel case-crossover designs	108
Predicting COVID-19 prognosis in the ICU remained challenging: external validation in a multinational regional cohort	106
Librarian involvement in systematic reviews was associated with higher quality of reported search methods: a cross-sectional survey	105
Methodological use and report of AMSTAR 2: a cross-sectional study	99
Integrating personomics into precision medicine	98
Reporting of funding and conflicts of interest improved from preprints to peer-reviewed publications of biomedical research	91
Statistical robustness of randomized controlled trials in high-impact journals has improved but was low across medical specialties	87
Evaluation of tools used to assess adherence to PRISMA 2020 reveals inconsistent methods and poor tool implementability: part I of a systematic review	84
Results reporting for clinical trials led by medical universities and university hospitals in the nordic countries was often missing or delayed	77
Measuring the environmental impact of health interventions in randomized controlled trials – A scoping review	76
The walking man approach to interpreting the receiver operating characteristic curve and area under the receiver operating characteristic curve	75

Whole population cohorts vs sampled comparators designs for evaluating health and educational outcomes of children with inborn rare conditions: a simulation study	72
Modified case-crossover estimators were unbiased in the presence of temporal trends in the exposure of interest: a simulation study	72
Harms were detected but not reported in six clinical trials of gabapentin	69
External validation of six COVID-19 prognostic models for predicting mortality risk in older populations in a hospital, primary care, and nursing home setting	67
Use of artificial intelligence to support the assessment of the methodological quality of systematic reviews	65
Advances in methodologies of negative controls: a scoping review	64
JBI series paper 2: tailored evidence synthesis approaches are required to answer diverse questions: a pragmatic evidence synthesis toolkit from JBI	63
Searching two or more databases decreased the risk of missing relevant studies: a metaresearch study	63
Justification of deferral of consent in the ACT-GLOBAL adaptive platform trial in stroke	59
Handling missing data in clinical research	59
GRADE guidance 39: using GRADE-ADOLOPMENT to adopt, adapt or create contextualized recommendations from source guidelines and evidence syntheses	58
Pharmacovigilance studies without a priori hypothesis: systematic review highlights inappropriate multiple testing correction procedures	57
External validation, impact assessment and clinical utilization of clinical prediction models: a prospective cohort study	54
Table of Contents	53
Editors' Choice September 2024	52
Editors’ Choice: October 2024	51
The World Conference on Research Integrity 2024	49
Table of Contents	47
Is it time for a common peer review format for biomedical journals?	47
A population-based recalibration method for updating survival neural networks models for cardiovascular risk prediction in United Kingdom and China	47
Table of Contents	46
Improved reporting of selection processes in clinical database research: author's reply	46
Prevalence of and factors associated with potentially redundant randomized controlled trials: a cross-sectional study	46